A systematic review of population pharmacokinetic analyses of polyclonal immunoglobulin G therapy.

International Immunopharmacology
Jian Lynn LeeShamin Mohd Saffian

Abstract

Population pharmacokinetics (popPK) using the nonlinear mixed-effect (NLME) modeling approach is an essential tool for guiding dose individualization. Several popPK analyses using the NLME have been conducted to characterize the pharmacokinetics of immunoglobulin G (IgG). To summarize the current information on popPK of polyclonal IgG therapy. A systematic search was conducted in the PubMed and Web of Science databases from inception to December 2020. Additional relevant studies were also included by reviewing the reference list of the reviewed articles. All popPK studies that employed the NLME modeling approach were included and data were synthesized descriptively. This review included seven studies. Most of the popPK models were developed in patients with primary immunodeficiency (PID). IgG pharmacokinetics was described as a two-compartment model in five studies, while it was described as a one-compartment model in two other studies. Among all tested covariates, weight was consistently identified as a significant predictor for clearance (CL) of IgG. Whereas, weight and disease type were found to be significant predictors for the volume of distribution in central compartment (Vc). In a typical 70 kg adult, the median estimate...Continue Reading

References

Dec 1, 1991·Journal of Clinical Pharmacology·K H RandJ Graham-Pole
Nov 1, 1989·The Pediatric Infectious Disease Journal·F J NoyaC J Baker
Nov 10, 1984·Lancet·K FurushoT Yokoyama
Mar 30, 1984·The American Journal of Medicine·B Pirofsky
Nov 26, 2002·Clinical Neurology and Neurosurgery·Brian Wegner, Iftekhar Ahmed
Apr 29, 2004·Journal of Clinical Immunology·Hans D OchsUNKNOWN Octagam Study Group
Jul 17, 2004·British Journal of Clinical Pharmacology·Bruce Green, Stephen B Duffull
Sep 16, 2004·The Annals of Pharmacotherapy·Ene I Ette, Paul J Williams
Apr 4, 2006·The Journal of Allergy and Clinical Immunology·Jordan S OrangeUNKNOWN Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
May 18, 2006·Journal of Clinical Immunology·Joseph A ChurchUNKNOWN US-PID-IGIV 10% -Study Group10
May 24, 2006·Pharmacotherapy·Tamar Koleba, Mary H H Ensom
Aug 23, 2007·British Journal of Clinical Pharmacology·C DartoisP Girard
Jul 8, 2008·The Journal of Allergy and Clinical Immunology·Vincent R BonaguraDavid W Rosenthal
Oct 23, 2008·Immunology and Allergy Clinics of North America·Francisco A Bonilla
Jun 6, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Richard L WassermanUNKNOWN IgPro10 in PID Study group
Nov 26, 2009·Annals of Neurology·Krista KuitwaardBart C Jacobs
Mar 11, 2010·Journal of Clinical Immunology·John W SleasmanMark R Stein
Jul 16, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·T FreibergerJ Litzman
Aug 3, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jordan S OrangeMahlon M Wilkes
Sep 8, 2010·Clinical Pharmacokinetics·Nathanael L Dirks, Bernd Meibohm
May 11, 2011·Clinical Pharmacokinetics·Richard L WassermanJoseph A Church
Jun 28, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·S JollesB Grimbacher
Jul 7, 2011·Clinical Reviews in Allergy & Immunology·Gisele Zandman-GoddardYehuda Shoenfeld
Aug 1, 2012·The Journal of Allergy and Clinical Immunology·Richard L WassermanUNKNOWN IGSC, 10% with rHuPH20 Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Computational Intelligence and Neuroscience
Carlos SepúlvedaRoberto Sepúlveda
Journal of Clinical Pharmacology
Monia GuidiThierry Buclin
Journal of Pharmacokinetics and Pharmacodynamics
Henning Schmidt, Andrijana Radivojevic
© 2021 Meta ULC. All rights reserved